Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
146 studies found for:    Open Studies | "Pre-Eclampsia"
Show Display Options
Rank Status Study
21 Recruiting Standard 24-hour Urine Protein vs Shorter Period for Diagnosis of Pre-eclampsia
Condition: Preeclampsia
22 Unknown  Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence
Condition: Pre-Eclampsia
23 Unknown  Physical Therapy in Pregnant Women With Preeclampsia
Condition: Preeclampsia
Interventions: Other: Physical therapy;   Other: No physical therapy
24 Not yet recruiting Saccadic Reaction Time and Preterm Pre-eclampsia
Condition: Pre-eclampsia
25 Unknown  PP13 and Doppler Study to Predict Preeclampsia
Condition: Preeclampsia
Interventions: Drug: Progesterone;   Drug: Low molecular weight Heparin;   Drug: No Drug
26 Not yet recruiting Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia
Conditions: Pre-eclampsia;   Pregnancy, High Risk;   Pregnancy Complications
Intervention: Other: Maternal plasma PlGF quantification
27 Unknown  Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)
Condition: Preeclampsia
Interventions: Drug: methildopa;   Drug: placebo
28 Not yet recruiting The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
Conditions: Hypertension;   Preeclampsia
Interventions: Drug: Urapidil;   Drug: Nicardipine
29 Recruiting Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
Condition: Preeclampsia
30 Not yet recruiting First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction
Conditions: Preeclampsia;   Intrauterine Growth Restriction
Interventions: Other: Ultrasound study of the placenta;   Other: Measurement of angiogenic and anti-angiogenic factors (sFlt-1 and PlGF) in the first trimestre blood test
31 Recruiting Pre-Eclampsia And Growth Restriction: a Longitudinal Study
Conditions: Preeclampsia;   Severe Preeclampsia;   Fetal Growth Restriction;   Preterm Birth
32 Not yet recruiting Evaluation of the Efficacy of Citrulline Supplementation on the Delay of Delivery for Women Hospitalized for Pre-eclampsia (CITRUPE)
Conditions: Pre-eclampsia;   Pregnancy
Interventions: Drug: Citrulline;   Drug: Placebo
33 Recruiting Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis
Condition: Preeclampsia
Intervention: Device: TheraSorb sFlt-1 adsorber
34 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
35 Recruiting EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
Conditions: Pre-eclampsia;   Intra-uterine Growth Retardation
Intervention: Other: blood sample and doppler Ultrasound of uterine arteries
36 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
37 Unknown  Investigating the Novel Observation of Right-Left Difference in Uterine Artery Vascular Resistance in Pre-Eclampsia
Condition: Pre-Eclampsia
Interventions: Drug: Epidural lidocaine;   Drug: Epidural lidocaine 2%
38 Recruiting Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia
Conditions: Severe Preeclampsia;   Postpartum Hemorrhage
Interventions: Drug: Carbetocin;   Drug: Oxytocin
39 Not yet recruiting Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery
Condition: Severe Pre-eclampsia
Interventions: Drug: Rosuvastatin;   Drug: Placebo
40 Unknown  The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR
Conditions: Pregnancy;   Preeclampsia

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years